AlPcS 4 -PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic ® F127 nanomicellar drug carriers.

MLA

Xin, Jing, et al. “AlPcS 4 -PDT for Gastric Cancer Therapy Using Gold Nanorod, Cationic Liposome, and Pluronic ® F127 Nanomicellar Drug Carriers.” International Journal of Nanomedicine, vol. 13, Apr. 2018, pp. 2017–36. EBSCOhost, https://doi.org/10.2147/IJN.S154054.

APA

Xin, J., Wang, S., Wang, B., Wang, J., Wang, J., Zhang, L., Xin, B., Shen, L., Zhang, Z., & Yao, C. (2018). AlPcS 4 -PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic ® F127 nanomicellar drug carriers. International Journal of Nanomedicine, 13, 2017–2036. https://doi.org/10.2147/IJN.S154054

Chicago

Xin, Jing, Sijia Wang, Bing Wang, Jiazhuang Wang, Jing Wang, Luwei Zhang, Bo Xin, Lijian Shen, Zhenxi Zhang, and Cuiping Yao. 2018. “AlPcS 4 -PDT for Gastric Cancer Therapy Using Gold Nanorod, Cationic Liposome, and Pluronic ® F127 Nanomicellar Drug Carriers.” International Journal of Nanomedicine 13 (April): 2017–36. doi:10.2147/IJN.S154054.